• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生存素与白血病

Survivin and leukemia.

作者信息

Cong Xiu Li, Han Zhong Chao

机构信息

State Key Laboratory of Experimental Hematology, Institute of Hematology and Hospital of Blood Diseases, Chinese Academy of Medical Sciences and Peking Union Medical College, Tianjin, China.

出版信息

Int J Hematol. 2004 Oct;80(3):232-8. doi: 10.1532/ijh97.a10408.

DOI:10.1532/ijh97.a10408
PMID:15540897
Abstract

Survivin is a unique member of the inhibitor-of-apoptosis family. Survivin plays a role in the proliferation and survival of normal hematopoietic cells. Survivin expression is aberrantly enhanced in most cancers and hematopoietic malignancies. Survivin is an attractive therapeutic target, and various approaches to targeting survivin have been tested in vitro and in vivo. We review here progress in survivin research.

摘要

生存素是凋亡抑制蛋白家族的一个独特成员。生存素在正常造血细胞的增殖和存活中发挥作用。在大多数癌症和造血系统恶性肿瘤中,生存素的表达异常增强。生存素是一个有吸引力的治疗靶点,针对生存素的各种方法已在体外和体内进行了测试。我们在此综述生存素研究的进展。

相似文献

1
Survivin and leukemia.生存素与白血病
Int J Hematol. 2004 Oct;80(3):232-8. doi: 10.1532/ijh97.a10408.
2
[Advance of research on survivin in hematological malignancies--review].[生存素在血液系统恶性肿瘤中的研究进展——综述]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2004 Dec;12(6):866-9.
3
[Research advances on inhibitor of apoptosis, survivin].[凋亡抑制因子Survivin的研究进展]
Ai Zheng. 2003 Jul;22(7):771-4.
4
The universal character of the tumor-associated antigen survivin.肿瘤相关抗原生存素的普遍特征。
Clin Cancer Res. 2007 Oct 15;13(20):5991-4. doi: 10.1158/1078-0432.CCR-07-0686.
5
Survivin and apoptosis control.生存素与细胞凋亡调控
Adv Cancer Res. 2003;88:31-52. doi: 10.1016/s0065-230x(03)88303-3.
6
Survivin: potential role in diagnosis, prognosis and targeted therapy of gastric cancer.生存素:在胃癌诊断、预后及靶向治疗中的潜在作用
World J Gastroenterol. 2007 May 28;13(20):2784-90. doi: 10.3748/wjg.v13.i20.2784.
7
[Sensitivity of survivin-positive primary leukemia cells to chemotherapy].[生存素阳性原发性白血病细胞对化疗的敏感性]
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Apr;13(2):266-8.
8
Survivin and its prognostic significance in pediatric acute B-cell precursor lymphoblastic leukemia.生存素及其在儿童急性B淋巴细胞白血病中的预后意义
Haematologica. 2007 Aug;92(8):1043-50. doi: 10.3324/haematol.10675. Epub 2007 Jul 20.
9
Overexpression of survivin initiates hematologic malignancies in vivo.Survivin 的过表达可引发体内血液系统恶性肿瘤。
Leukemia. 2010 Nov;24(11):1920-6. doi: 10.1038/leu.2010.198. Epub 2010 Sep 30.
10
Survivin, cancer networks and pathway-directed drug discovery.生存素、癌症网络与通路导向的药物发现
Nat Rev Cancer. 2008 Jan;8(1):61-70. doi: 10.1038/nrc2293.

引用本文的文献

1
FLI1 promotes protein translation via the transcriptional regulation of MKNK1 expression.FLI1 通过调节 MKNK1 表达促进蛋白质翻译。
Int J Oncol. 2020 Feb;56(2):430-438. doi: 10.3892/ijo.2019.4943. Epub 2019 Dec 16.
2
Therapeutic Potency of Nanoformulations of siRNAs and shRNAs in Animal Models of Cancers.小干扰RNA(siRNA)和短发夹RNA(shRNA)纳米制剂在癌症动物模型中的治疗效力
Pharmaceutics. 2018 May 26;10(2):65. doi: 10.3390/pharmaceutics10020065.
3
Artificial human antigen-presenting cells are superior to dendritic cells at inducing cytotoxic T-cell responses.

本文引用的文献

1
Survivin expression predicts poorer prognosis in anaplastic large-cell lymphoma.Survivin表达预示间变性大细胞淋巴瘤预后较差。
J Clin Oncol. 2004 May 1;22(9):1682-8. doi: 10.1200/JCO.2004.10.172.
2
Survivin enhances Fas ligand expression via up-regulation of specificity protein 1-mediated gene transcription in colon cancer cells.生存素通过上调特异性蛋白1介导的基因转录增强结肠癌细胞中Fas配体的表达。
J Immunol. 2004 Mar 15;172(6):3922-9. doi: 10.4049/jimmunol.172.6.3922.
3
Knockdown of survivin expression by small interfering RNA reduces the clonogenic survival of human sarcoma cell lines independently of p53.
人工人类抗原呈递细胞在诱导细胞毒性T细胞反应方面优于树突状细胞。
Immunology. 2017 Nov;152(3):462-471. doi: 10.1111/imm.12783. Epub 2017 Jul 27.
4
Phase I study of the novel Cdc2/CDK1 and AKT inhibitor terameprocol in patients with advanced leukemias.新型Cdc2/CDK1及AKT抑制剂特拉米普洛用于晚期白血病患者的I期研究。
Invest New Drugs. 2015 Apr;33(2):389-96. doi: 10.1007/s10637-014-0198-y. Epub 2014 Dec 19.
5
Survivin as a preferential target for cancer therapy.生存素作为癌症治疗的优先靶点。
Int J Mol Sci. 2014 Feb 13;15(2):2494-516. doi: 10.3390/ijms15022494.
6
Detection and preliminary characterization of CD8+T lymphocytes specific for Wilms' tumor antigen in patients with non-Hodgkin lymphoma.检测和初步鉴定非霍奇金淋巴瘤患者中针对 Wilms 瘤抗原的 CD8+T 淋巴细胞。
Leuk Lymphoma. 2013 Nov;54(11):2490-9. doi: 10.3109/10428194.2013.783910. Epub 2013 Apr 30.
7
Safety and pharmacokinetics of the antisense oligonucleotide (ASO) LY2181308 as a single-agent or in combination with idarubicin and cytarabine in patients with refractory or relapsed acute myeloid leukemia (AML).在难治性或复发性急性髓细胞白血病(AML)患者中,作为单一药物或与伊达比星和阿糖胞苷联合使用时,反义寡核苷酸(ASO)LY2181308 的安全性和药代动力学。
Invest New Drugs. 2013 Aug;31(4):1023-34. doi: 10.1007/s10637-013-9935-x. Epub 2013 Feb 10.
8
Survivin selective inhibitor YM155 induce apoptosis in SK-NEP-1 Wilms tumor cells.Survivin 选择性抑制剂 YM155 诱导 SK-NEP-1 肾母细胞瘤细胞凋亡。
BMC Cancer. 2012 Dec 26;12:619. doi: 10.1186/1471-2407-12-619.
9
Overexpression of survivin initiates hematologic malignancies in vivo.Survivin 的过表达可引发体内血液系统恶性肿瘤。
Leukemia. 2010 Nov;24(11):1920-6. doi: 10.1038/leu.2010.198. Epub 2010 Sep 30.
10
TEL-AML1 regulation of survivin and apoptosis via miRNA-494 and miRNA-320a.TEL-AML1 通过 microRNA-494 和 microRNA-320a 调控存活素和细胞凋亡。
Blood. 2010 Dec 2;116(23):4885-93. doi: 10.1182/blood-2009-02-206706. Epub 2010 Aug 31.
通过小分子干扰RNA抑制生存素表达可降低人肉瘤细胞系的克隆存活能力,且与p53无关。
Cancer Gene Ther. 2004 Mar;11(3):186-93. doi: 10.1038/sj.cgt.7700677.
4
Down-regulation of survivin expression reversed multidrug resistance in adriamycin-resistant HL-60/ADR cell line.生存素表达的下调逆转了阿霉素耐药HL-60/ADR细胞系中的多药耐药性。
Acta Pharmacol Sin. 2003 Dec;24(12):1235-40.
5
Targeting Survivin expression induces cell proliferation defect and subsequent cell death involving mitochondrial pathway in myeloid leukemic cells.靶向Survivin表达可诱导髓系白血病细胞出现细胞增殖缺陷,并随后通过线粒体途径导致细胞死亡。
Cell Cycle. 2003 Sep-Oct;2(5):488-93.
6
Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis.凋亡抑制因子survivin在口腔癌发生过程中的表达
J Dent Res. 2003 Aug;82(8):607-11. doi: 10.1177/154405910308200807.
7
Therapeutic targeting of the survivin pathway in cancer: initiation of mitochondrial apoptosis and suppression of tumor-associated angiogenesis.癌症中生存素通路的治疗靶向:启动线粒体凋亡并抑制肿瘤相关血管生成。
Clin Cancer Res. 2003 Jul;9(7):2683-92.
8
Blocking survivin to kill cancer cells.阻断生存素以杀死癌细胞。
Methods Mol Biol. 2003;223:533-42. doi: 10.1385/1-59259-329-1:533.
9
Generation of cytotoxic responses in mice and human individuals against hematological malignancies using survivin-RNA-transfected dendritic cells.使用survivin-RNA转染的树突状细胞在小鼠和人类个体中产生针对血液系统恶性肿瘤的细胞毒性反应。
J Immunol. 2003 Jun 1;170(11):5391-7. doi: 10.4049/jimmunol.170.11.5391.
10
Expression of the antiapoptotic gene survivin in chronic myeloid leukemia.抗凋亡基因生存素在慢性髓性白血病中的表达
Anticancer Res. 2003 Jan-Feb;23(1B):589-92.